Decreased sensitivity of human platelets to PGI2 during long-term intraarterial prostacyclin infusion in patients with peripheral vascular disease--a rebound phenomenon?

Prostaglandins
H SinzingerA Gall

Abstract

During successful treatment of peripheral vascular disease with synthetic prostacyclin no alteration in platelet function was reported (1). In 8 patients infused with synthetic prostacyclin continuously for 7 days intraarterially, the platelet function was monitored. Special attention was drawn to the platelet sensitivity in vitro for PGI2, which is discussed as an important factor maintaining the hemostatic balance. In all the patients with peripheral vascular disease between 24 and 48 hours after the beginning of the infusion a sudden decrease in platelet sensitivity accompanied by an increase in platelet count could be seen. These dramatic alterations representing probably a rebound phenomenon occurring during long-term PGI2-treatment might be an explanation for a non-beneficial effect of the treatment and in some cases a limiting factor for the continuation of the infusion itself. It is not clear, if this rebound phenomenon is due to a stimulation of an endogenous inhibitor, lowering the synthesis of a naturally occurring substance acting against this inhibitor or tachyphylaxia.

References

Sep 1, 1979·Lancet·H SinzingerK Silberbauer
Feb 15, 1979·The New England Journal of Medicine·M SchydlowerP H Patterson
Jan 1, 1984·Respiration; International Review of Thoracic Diseases·O C BurghuberC Leithner

❮ Previous
Next ❯

Citations

Jan 1, 1987·European Journal of Clinical Pharmacology·U Müller-BühlH H Eckstein
Sep 1, 1985·Basic Research in Cardiology·K Schrör
May 1, 1981·Prostaglandins·A Dembinska-KiecT Zelazny
Jan 1, 1990·Pharmacology & Therapeutics·G J Dusting, P S MacDonald
Mar 1, 1983·Prostaglandins, Leukotrienes, and Medicine·B A SchölkensW Jung
Oct 1, 1985·Prostaglandins, Leukotrienes, and Medicine·S D KristensenJ Dyerberg
Jun 1, 1986·Prostaglandins, Leukotrienes, and Medicine·P PolterauerB A Peskar
Feb 1, 1986·Prostaglandins, Leukotrienes, and Medicine·P PolterauerB A Peskar
Sep 1, 1986·Prostaglandins, Leukotrienes, and Medicine·H SinzingerB A Peskar
Nov 1, 1996·Burns : Journal of the International Society for Burn Injuries·M N BattalT Kawazoe
Sep 29, 1984·Lancet·H SinzingerK Silberbauer
Jan 1, 1996·Pharmacology & Therapeutics·R A Armstrong
May 1, 1997·Burns : Journal of the International Society for Burn Injuries·M N BattalM Nagao
Apr 1, 1991·British Journal of Clinical Pharmacology·P A ModestiG G Neri Serneri
Jul 8, 1998·Prostaglandins, Leukotrienes, and Essential Fatty Acids·M SchirnerM Hildebrand
Dec 1, 1994·Thrombosis Research·M Rodrigues, H Sinzinger
Dec 15, 1987·Thrombosis Research·P A ModestiG F Gensini
Mar 15, 1983·Thrombosis Research·A SzczeklikM Palester-Chlebowczyk
Dec 1, 1981·Prostaglandins and Medicine·J H Botha, W P Leary
Jan 1, 1990·Thrombosis Research. Supplement·E TremoliR Paoletti
Sep 1, 1988·Pharmacological Research Communications·H Sinzinger
Sep 1, 1988·Pharmacological Research Communications·P MadernaR Paoletti
Jun 1, 1982·Pharmacological Research Communications·A Dembińska-KiećT Zelazny
Oct 1, 1982·Pharmacological Research Communications·R J GryglewskiS Szmatoła
Feb 1, 1988·European Journal of Clinical Investigation·K Jaschonek, C P Muller
Sep 1, 1982·British Journal of Pharmacology·I A BlairJ MacDermot
Feb 1, 1986·Journal of Clinical Pharmacology·O I LinetC A Greenwald
Jan 1, 1991·Platelets·E H Horn
Mar 1, 1996·Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery·K AlexandrouH Matsuda
Apr 1, 1988·Journal of Clinical Pharmacology·E LichsteinO I Linet
Dec 1, 1986·European Journal of Clinical Investigation·A CreutzigK Alexander

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.